In recent years, womb transplants have emerged as a remarkable solution for women suffering from uterine factor infertility—a condition affecting approximately 3-5% of women worldwide. This advanced procedure, still in its experimental stages, is providing new hope for those who previously had limited options for motherhood.
Womb transplants offer a groundbreaking opportunity for women born without a uterus, those with a malformed uterus, or women who have experienced complications requiring a hysterectomy. The first successful womb transplant that led to live birth occurred in Sweden in 2014, a milestone that spurred interest and development in this area of reproductive medicine globally.
In India, the first such procedure was conducted in 2017 by surgeons at Galaxy Care Hospital in Pune. Two consecutive womb transplants were performed; the first was on a 21-year-old woman born without a womb, using her mother’s uterus, and the second on a 24-year-old woman. This pioneering work in India laid the foundation for future advancements in the field.
The surgical procedure involves the delicate removal of the donor’s uterus, which can be from living relatives or deceased donors, followed by the transplant into the recipient. Utilizing minimally invasive techniques helps reduce recovery times and complications. Once the uterus is successfully transplanted, the recipient typically requires about six months to heal before attempting to conceive. Post-surgery, women are often prescribed immunosuppressants to prevent the body from rejecting the transplanted organ.
Research indicates that approximately 74% of uterus transplants remain functional one year after the surgery, with nearly 58% resulting in live births. Since the first successful transplant in India, notable achievements include the birth of the first baby from a transplanted uterus in October 2018 at Galaxy Care Hospital, weighing a healthy 1.45 kg.
Although the procedure has shown promise, it remains highly experimental, with only a few specialized centers offering it. The complexity and strict eligibility criteria for both donors and recipients limit accessibility. In India, the procedure is regulated under the National Organ & Tissue Transplant Organisation (NOTTO) Act, ensuring that medical criteria are met for the safety and health of both the donor and recipient.
Cost is another significant consideration. The total expense for a uterus transplant in India can range between Rs 10 lakh to Rs 25 lakh (approximately $13,000 to $31,000), encompassing surgery, hospital care, and post-op treatments. Given the experimental nature of the procedure, insurance coverage may be limited, making it financially burdensome for many potential recipients.
As medical expertise advances and the understanding of womb transplants expand, there is potential for these procedures to become more accessible in the future. The success stories emerging from various countries, including India, indicate that womb transplants could play a crucial role in alleviating infertility concerns among women facing unique challenges related to uterine health.
-Raja Aditya
